Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment

被引:74
|
作者
Zhang, Xiaodong
Dong, Lei
Lee, Andrew K.
Cox, James D.
Kuban, Deborah A.
Zhu, Ron X.
Wang, Xiaochun
Li, Yupeng
Newhauser, Wayne D.
Gillin, Michael
Mohan, Radhe
机构
[1] Univ Texas, MD Anderson Canc Ctr, Unit 94, Dept Radiat Phys, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 67卷 / 02期
关键词
proton therapy; image-guided radiotherapy; intensity-modulated radiation therapy; organ motion;
D O I
10.1016/j.ijrobp.2006.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the dosimetric impact of interfraction anatomic movements in prostate cancer patients receiving proton therapy. Methods and Materials: For each of the 10 patients studied, 8 computed tomography (CT) scans were selected from sets of daily setup CT images that were acquired from a cohort of prostate cancer patients. The images were acquired in the treatment room using the CT-on-rails system. First, standard proton therapy and intensity-modulated radiation therapy (IMRT) plans were designed for each patient using standard modality-specific methods. The images, the proton plan, and the IMRT plan were then aligned to the eight CT images based on skin marks. The doses were recalculated on these eight CT images using beam from the standard plans. Second, the plans were redesigned and evaluated assuming a smaller clinical target volume to planning target volume margin (3 mm). The images and the corresponding plans were then realigned based on the center of volume of the prostate. Dose distributions were evaluated using isodose displays, dose-volume histograms, and target coverage. Results: For the skin-marker alignment method, 4 of the 10 IMRT plans were deficient, whereas 3 of 10 proton plans were compromised. For the alignment method based on the center of volume of the prostate, only the proton plan for 1 patient was deficient, whereas 3 of the 10 IMRT plans were suboptimal. Conclusion: A comparison of passively scattered proton therapy and highly conformal IMRT plans for prostate cancer revealed that the dosimetric impact of interfractional anatomic motions was similar for both modalities. (c) 2007 Elsevier Inc.
引用
收藏
页码:620 / 629
页数:10
相关论文
共 50 条
  • [1] EFFECTS OF INTERFRACTIONAL, MOTION AND ANATOMIC CHANGES ON PROTON THERAPY DOSE DISTRIBUTION IN LUNG CANCER
    Hui, Zhouguang
    Zhang, Xiaodong
    Starkschall, George
    Li, Yupeng
    Mohan, Radhe
    Komaki, Ritsuko
    Cox, James D.
    Chang, Joe Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (05): : 1385 - 1395
  • [2] Hypofractionated proton therapy for prostate cancer: Dose delivery uncertainty due to interfractional motion
    Wang, Yi
    Efstathiou, Jason A.
    Lu, Hsiao-Ming
    Sharp, Gregory C.
    Trofimov, Alexei
    MEDICAL PHYSICS, 2013, 40 (07)
  • [3] Proton Beam Therapy for the Treatment of Prostate Cancer
    Pugh, Thomas J.
    Lee, Andrew K.
    CANCER JOURNAL, 2014, 20 (06): : 415 - 420
  • [4] Comparative analysis of dose distribution in photon and proton therapy of prostate cancer
    Smyslov A.Yu.
    Konchili I.N.
    Lebedev L.A.
    Khmelevskii E.V.
    Biomedical Engineering, 2006, 40 (5) : 229 - 232
  • [5] Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility
    Maeda, Yoshikazu
    Sato, Yoshitaka
    Minami, Hiroki
    Yasukawa, Yutaka
    Yamamoto, Kazutaka
    Tamamura, Hiroyasu
    Shibata, Satoshi
    Bou, Sayuri
    Sasaki, Makoto
    Tameshige, Yuji
    Kume, Kyo
    Ooto, Hiroshi
    Kasahara, Shigeru
    Shimizu, Yasuhiro
    Saga, Yusuke
    Omoya, Akira
    Saitou, Makoto
    MEDICAL PHYSICS, 2018, 45 (05) : 1832 - 1843
  • [6] Out-of-field dose equivalents delivered by proton therapy of prostate cancer
    Wroe, Andrew
    Rosenfeld, Anatoly
    Schulte, Reinhard
    MEDICAL PHYSICS, 2007, 34 (09) : 3449 - 3456
  • [7] Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
    Bhangoo, Ronik S.
    Petersen, Molly M.
    Bulman, Gabriella F.
    Vargas, Carlos E.
    Thorpe, Cameron S.
    Shen, Jason
    Wong, William W.
    Rwigema, Jean-Claude M.
    Daniels, Thomas B.
    Keole, Sameer R.
    Schild, Steven E.
    Rong, Yi
    DeWees, Todd A.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2022, 8 (04) : 37 - 46
  • [8] Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer
    Giebeler, Annelise
    Fontenot, Jonas
    Balter, Peter
    Ciangaru, George
    Zhu, Ronald
    Newhauser, Wayne
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2009, 10 (01): : 63 - 70
  • [9] Effect of DIR uncertainty on prostate passive-scattering proton therapy dose accumulation
    Abe, Yoshitomo
    Kadoya, Noriyuki
    Arai, Kazuhiro
    Takayama, Yoshiki
    Kato, Takahiro
    Kimura, Kanako
    Ono, Takashi
    Nakamura, Tatsuya
    Wada, Hitoshi
    Kikuchi, Yasuhiro
    Jingu, Keiichi
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 39 : 113 - 120
  • [10] Calculation of clinical dose distributions in proton therapy from microdosimetry
    Bertolet, Alejandro
    Antonio Cortes-Giraldo, Miguel
    Souris, Kevin
    Cohilis, Marie
    Carabe-Fernandez, Alejandro
    MEDICAL PHYSICS, 2019, 46 (12) : 5816 - 5823